Boulder facility

New owner for Boulder Scientific

16th November 2026

Submitted by:

Andrew Warmington

Private equity firm Iron Path Capital has acquired Boulder Scientific (BSC) from Quad-C Management in the first investment from Iron Path Capital Fund II, a $450 million partnership. Terms were not disclosed.

BSC supplies metallocene catalysts for polyolefins and other products for the microelectronics, semiconductor, pharmaceuticals, aerospace and defence industries. It also claims to be “one of the few organometallic material manufacturers in North America at scale not affiliated with a tier one supplier to semiconductor chip manufacturers”.

Iron Path focuses on investing in companies within speciality chemicals and materials, engineered products and technical services that sell into highly regulated end markets. It commented that BSC “is a differentiated, technically driven business that clearly aligns with our strategy of partnering with technical companies that have unique capabilities”.

In March 2025, BSC completed investments at two facilities in Mead and Longmont, Colorado, including a cleanroom to enable detection of trace metals to ppb level, and low-volume and commercial-scale purification and distillation equipment to meet the very low trace metal specifications for metal precursors for semiconductor chip fabrication.

This also expanded multi-purpose synthesis capacity by 20% to produce a novel silane polymer for advanced composite parts for aerospace applications and for the manufacture traditional organometallic compounds. Two further large-scale enhancements were planned in the next few years at Longmont.